Clinical Trials Browser

Nasopharyngeal Carcinoma, Bile Duct Neoplasms, Carcinoma, Basal Cell, Adenocarcinoma, Bronchiolo-Alveolar, Adenocarcinoma, Mucinous, Carcinoma, Transitional Cell, Carcinosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Gallbladder Neoplasms, Hemangiosarcoma, Mouth Neoplasms, Paget Disease, Extramammary, Paraganglioma, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Thyroid Neoplasms, Vulvar Neoplasms, Desmoid Tumors, Seminoma, Carcinoma, Acinar Cell, Adrenocortical Carcinoma, Carcinoma, Endometrioid, Cholangiocarcinoma, Cystadenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Carcinoma, Giant Cell, Neurofibrosarcoma, Gestational Trophoblastic Disease, Rare Diseases, Gastrointestinal Stromal Tumors, Perivascular Epithelioid Cell Neoplasms

NCT06084780 2026-04-09

TRANSCAPE

Phase 2 Not yet recruiting

20 enrolled

Pseudomyxoma Peritonei

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 Recruiting

100 enrolled

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06617897 2026-03-11

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Phase 3 Recruiting

90 enrolled

Afibrinogenemia, Blood Coagulation Disorders, Pseudomyxoma Peritonei

NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Recruiting

500 enrolled

GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06513065 2026-02-19

HIPEC-PMP

Phase 3 Recruiting

176 enrolled

Pseudomyxoma Peritonei

NCT07378371 2026-01-30

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

Phase NA Not yet recruiting

174 enrolled

Emergence Delirium, Pseudomyxoma Peritonei

NCT04024917 2026-01-16

COCOON

Phase NA Recruiting

60 enrolled

Gynecologic

Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT07341360 2026-01-14

Pseudovax

Phase EARLY_PHASE1 Recruiting

10 enrolled

Pseudomyxoma Peritonei

NCT07328737 2026-01-09

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Phase NA Recruiting

132 enrolled

Pseudomyxoma Peritonei

NCT06839378 2026-01-06

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Phase NA Completed

36 enrolled 8 charts

Pseudomyxoma Peritonei

NCT04665921 2025-02-07

A Study of SGN-STNV in Advanced Solid Tumors

Phase 1 Terminated

111 enrolled

GastrointestinalGynecologicThoracic

Adenocarcinoma, Mucinous, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06800391 2025-01-30

REVERSE

Phase 2 Recruiting

31 enrolled

Pseudomyxoma Peritonei

NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Phase 2 Active not recruiting

80 enrolled

Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Phase 2 Completed

51 enrolled 12 charts

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT01617382 2024-06-26

HIPEC

Recruiting

125 enrolled

Gynecologic

Fever, Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT05513183 2023-08-07

Severe Neutropenia After HIPEC Using Mitomycin-C

Completed

74 enrolled

Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

NCT02599116 2023-03-27

Gastrointestinal Microbiome Study of Appendiceal Cancer

Phase NA Unknown

24 enrolled

Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

NCT04982146 2022-06-02

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Phase 1 Unknown

10 enrolled

Pseudomyxoma Peritonei

NCT04088786 2022-05-06

Phase I Trial HIPEC With Nal-irinotecan

Phase 1 Completed

18 enrolled

GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma, Mucinous, Mesothelioma, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT05321329 2022-04-11

ACAPP

Phase 2 Unknown

28 enrolled

Pseudomyxoma Peritonei

NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Phase 2 Unknown

62 enrolled

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

NCT05185791 2022-01-11

ERAS® Guidelines Validation of CRS With or Without HIPEC

Unknown

288 enrolled

Peritoneal Diseases, Pseudomyxoma Peritonei

NCT02073500 2021-07-28

PSM

Recruiting

300 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Ovarian Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT04125225 2020-01-31

What Are the Experiences of Patients With Pseudomyxoma Peritonei?

Withdrawn

Pseudomyxoma Peritonei

NCT03210298 2019-10-08

PIPACRegis

Unknown

1,000 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT01126346 2018-07-03

HOPE

Phase NA Completed

10 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

NCT02949791 2018-02-23

HIPEC-IAP

Phase 2 Completed

38 enrolled

Gastrointestinal

Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02834169 2017-08-22

RENAPE

Unknown

2,171 enrolled

Pseudomyxoma Peritonei, Cystadenocarcinoma, Serous, Desmoplastic Small Round Cell Tumor

NCT02374411 2017-02-08

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Completed

55 enrolled

GastrointestinalGynecologicSarcoma

Adenocarcinoma, Appendiceal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Pseudomyxoma Peritonei, Sarcoma, Uterine Neoplasms

NCT03034850 2017-01-27

Thrombin Generation and Platelet Activation in CRS/HIPEC

Completed

27 enrolled

GynecologicOther solid neoplasmThoracic

Mesothelioma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Phase NA Completed

39 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

NCT01652794 2015-08-04

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Phase 1 Completed

12 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Leydig Cell Tumor, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT01427101 2011-09-01

Results of CRS and Debulking in PMP Patients

Unknown

Pseudomyxoma Peritonei

NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Phase 1 Completed

CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Clinical Trials

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

TRANSCAPE

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

HIPEC-PMP

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

COCOON

Pseudovax

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

A Study of SGN-STNV in Advanced Solid Tumors

REVERSE

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

HIPEC for Peritoneal Carcinomatosis

HIPEC

Severe Neutropenia After HIPEC Using Mitomycin-C

Gastrointestinal Microbiome Study of Appendiceal Cancer

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Phase I Trial HIPEC With Nal-irinotecan

ACAPP

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

ERAS® Guidelines Validation of CRS With or Without HIPEC

PSM

What Are the Experiences of Patients With Pseudomyxoma Peritonei?

PIPACRegis

HOPE

HIPEC-IAP

RENAPE

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Thrombin Generation and Platelet Activation in CRS/HIPEC

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Results of CRS and Debulking in PMP Patients

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum